Article
Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal
Neutral
0.0
−100 Bearish
0
+100 Bullish
Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about $14.5 billion to expand its portfolio of cardiovascular devices.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
CNBC Top Stories
Published
Jan 15, 2026 · 12:47 pm
Article ID
1ej0pmi
Original URL
Open source
Sentiment Signal
Neutral
0.0
−100Neutral+100
More Like This